Analysts at GMI Research indicates that the Needle Free Injection Systems Market is estimated to grow at a CAGR of 16.2% from 2022-2029.

The factors driving the growth of Needle Free Injection Systems Market includes growing rate of infectious diseases such as malaria, increasing demand for large-molecule drugs around the world, rising prevalence of diabetes, hepatitis and cancer and improvements in the living standards. According to the report published by World Health Organization, around 241 million cases of malaria were reported in 2020 and 627,000 died due to malaria worldwide in the same year 2020, showing an increase of 14 million cases as compared to 2019, which is pushing the demand for needle free injection systems. Moreover, increasing adoption of advanced technologies such as artificial intelligence (AI) and bar code identification (BI), by clinicians and pharmacists, growing popularity of self-injection devices, fall in the prices of injection systems and rapid urbanization, are some of the additional factors supplementing the Needle Free Injection Systems Market size. In addition, the increasing investments by major companies on research and development, rising disposable incomes and growing population growth rates, are further contributing towards the market growth.

Request For a FREE Sample Report on Needle Free Injection Systems Market

As per the Needle-Free Injection Systems Market Trends, strict regulations regarding the manufacturing of needle free injection devices, is restricting the market growth.

The major players operating in the market are European Pharma Group, Penject Corporation, Crossject. Pharmajet, Bioject Medical Technologies Inc. (Acquired by Inovio Pharmaceuticals, Inc.), Medical International Technology, Inc. (MIT), Antares Pharma, Inc., Endo International PLC., Injex Pharma AG, National Medical Products, Inc. and Valeritas, Inc., among others.

Based on Product, the Fillable Needle Free Injectors segment is predicted to dominate the market during the forecast period

According to the Needle Free Injection Systems Market Analysis, rising prevalence of chronic diseases worldwide and growing demand for vaccinations, are some of the factors responsible for the segment’s growth.

Based on Technology, the Jet Based Needle Free Injectors segment is projected to lead the market over the forecast period

As per the Needle Free Injection Systems Market Reports, jet-based needle free injectors help in drug administration and enhances dosage accuracy, are propelling growth of the segment.

Based on Region, the European region is anticipated to hold the highest market share during the forecast period

As per the Needle Free Injection Systems Market Forecast, increase in the ageing population, rising prevalence of diabetes and cancer across Untied Kingdom and Germany, improved living standards, rapid industrialization, and high per capita incomes, are some of the important factors augmenting the market growth in European region.

Market Segmentation

Segmentation by Product

• Fillable Needle Free Injectors
• Prefilled Needle Free Injectors

Segmentation by Technology

• Jet Based Needle Free Injectors
• Spring Based Needle Free Injectors
• Laser Powered Needle Free Injectors
• Vibration Based Needle Free Injectors

Segmentation by Region

• Asia Pacific
  • China
  • Japan
  • India
  • Rest of APAC
• North America
  • United States of America
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Rest of Europe
• RoW
  • Brazil
  • South Africa
  • Saudi Arabia
  • UAE

About GMI Research

GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.

Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: [email protected]
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com